Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion

IMPORTANCE: Expanding Medicaid eligibility could affect prescriptions of buprenorphine with naloxone, an established treatment for opioid use disorder, and opioid pain relievers (OPRs). OBJECTIVE: To examine changes in prescriptions of buprenorphine with naloxone and OPRs after the US Affordable Car...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Netw Open
Hlavní autoři: Saloner, Brendan, Levin, Jonathan, Chang, Hsien-Yen, Jones, Christopher, Alexander, G. Caleb
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2018
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324520/
https://ncbi.nlm.nih.gov/pubmed/30646116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.1588
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky